Literature DB >> 15642318

The native oligomeric organization of alpha-crystallin, is it necessary for its chaperone function?

Joseph Horwitz1, Qingling Huang, Linlin Ding.   

Abstract

Citraconylation of all the lysine residues of alpha B and alpha A disrupts the native oligomeric state of these proteins. For alpha B, the oligomerization is concentration dependent with monomers and dimers formed at low protein concentration (approximately 0.01 mg ml(-1)). For concentration higher than 0.5 mg ml(-1) tetramers are the major species. Citraconylated alpha A crystallin is mostly tetrameric at any concentration. Citraconylation had a major effect on the secondary structure of alpha B which was reflected by a significant loss of beta-sheet structure. On the other hand, the secondary structure of alpha A crystallin was not significantly effected by this chemical modification. The chaperone properties of both modified proteins were the same as the native proteins when apo alpha-lactalbumin and malate dehydrogenase were used as target proteins. The data suggest that the native oligomeric state of alpha-crystallin may not be essential for its ability to suppress non-specific aggregation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15642318     DOI: 10.1016/j.exer.2004.05.007

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  17 in total

1.  Crystal structures of truncated alphaA and alphaB crystallins reveal structural mechanisms of polydispersity important for eye lens function.

Authors:  Arthur Laganowsky; Justin L P Benesch; Meytal Landau; Linlin Ding; Michael R Sawaya; Duilio Cascio; Qingling Huang; Carol V Robinson; Joseph Horwitz; David Eisenberg
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

2.  Truncation of alphaB-crystallin by the myopathy-causing Q151X mutation significantly destabilizes the protein leading to aggregate formation in transfected cells.

Authors:  Victoria H Hayes; Glyn Devlin; Roy A Quinlan
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

3.  Co-chaperoning by amyloid-forming proteins: cystatins vs. crystallins.

Authors:  Eva Žerovnik
Journal:  Eur Biophys J       Date:  2017-05-06       Impact factor: 1.733

4.  Conserved F84 and P86 residues in alphaB-crystallin are essential to effectively prevent the aggregation of substrate proteins.

Authors:  Puttur Santhoshkumar; K Krishna Sharma
Journal:  Protein Sci       Date:  2006-11       Impact factor: 6.725

5.  Hydroimidazolone modification of human alphaA-crystallin: Effect on the chaperone function and protein refolding ability.

Authors:  Mahesha H Gangadhariah; Benlian Wang; Mikhail Linetsky; Christian Henning; Robert Spanneberg; Marcus A Glomb; Ram H Nagaraj
Journal:  Biochim Biophys Acta       Date:  2010-01-18

6.  Chemical modulation of the chaperone function of human alphaA-crystallin.

Authors:  Ashis Biswas; Shawn Lewis; Benlian Wang; Masaru Miyagi; Puttur Santoshkumar; Mahesha H Gangadhariah; Ram H Nagaraj
Journal:  J Biochem       Date:  2008-03-15       Impact factor: 3.387

7.  The interaction of unfolding α-lactalbumin and malate dehydrogenase with the molecular chaperone αB-crystallin: a light and X-ray scattering investigation.

Authors:  Justyn W Regini; Heath Ecroyd; Sarah Meehan; Kristen Bremmell; Matthew J Clarke; Donna Lammie; Tim Wess; John A Carver
Journal:  Mol Vis       Date:  2010-11-18       Impact factor: 2.367

Review 8.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

Review 9.  Alpha crystallin: the quest for a homogeneous quaternary structure.

Authors:  Joseph Horwitz
Journal:  Exp Eye Res       Date:  2008-07-25       Impact factor: 3.467

10.  The thermal structural transition of α-crystallin inhibits the heat induced self-aggregation.

Authors:  Giuseppe Maulucci; Massimiliano Papi; Giuseppe Arcovito; Marco De Spirito
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.